Elytron is an industrial deeptech platform that accelerates the discovery and development of high-efficacy biological products. By combining large-scale biological mapping, AI, multi-omics, and industrial formulation, we have built a systematic platform that advances biological assets from discovery to industrial prototype in six months. With a proprietary bank of more than 1,500 microorganisms, we have active operations and commercial presence in Brazil and Argentina. Products developed through Elytron have demonstrated superior efficacy across multiple agroindustrial field campaigns, while the company expands its capabilities into additional industrial verticals, including Food and Oil & Gas.
| Website | https://www.elytronbiotech.com/ |
| Employees | 16 (12 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology Research |
| Keywords | Biotech Solutions, Biotechnology, Biotech Platform, Innovative Technology, Microbial Analysis, Microbial Identification, Digital Platform, Mapping Technology, Technology Platform, Process Optimization, Product Development, Scientific Solutions, Drug Discovery, R&D, Research Tools, Advanced Analytics, Candidate Selection, Data Analysis |
| Competitors | Amgen, Evonik, Novozymes, Twist Bioscience, Codexis, Inc., Geno, Zymergen, Inc., Bolt Threads, Ceres, Inc. +32 more (view full list) |
Looking for a particular Elytron employee's phone or email?
Ezequiel Naftali is the CTO of Elytron.
12 people are employed at Elytron.